Schizophrenia/Psychosis

Is cannabis’ effect on schizophrenia being downplayed?

Dr. Sanjai Rao and nurse practitioner Kimberly Garcia explain the barriers patients face in getting treatment with long-acting injectables and how COVID-19 has affected patient care.

Experts discuss the advantages of using the longest-acting injection formulation to treat schizophrenia, and whether there’s a need to discuss LAIs with patients from onset of illness.

Kimberly Garcia, DNP, CRNP, and Sanjai Rao, MD, DFAPA, review the administration frequencies of long acting injectables risperidone, aripiprazole, and paliperidone.

Sanjai Rao, MD, DFAPA, starts a conversation on how to discuss long acting injectables with patients and how to best transition from an oral medication.

Nurse Practitioner Kimberly Garcia and Dr. Sanjai Rao have a discussion on how they treat schizophrenia and highlight the considerations of prescribing long-acting injectables.

Key opinion leaders comment on how to monitor and increase patient treatment adherence to prevent relapse.

Sanjai Rao, MD, DFAPA, and Kimberly Garcia, DNP, CRNP, discuss how practitioners diagnose a schizophrenia relapse, and how to discuss relapse with patients.

Kimberly Garcia, DNP, CRNP, explains how widespread schizophrenia is and the challenges and unmet needs of treatment.

What treatment strategies are available to improve the quality of life for older adults who are aging with schizophrenia?

Should we go up? Researchers performed a dose-response meta-analysis of randomized controlled trials in acute phase schizophrenia.

Does clozapine increase the risk of severe COVID-19 infection? Researchers performed a larger register-based cohort study of this association.

Negative symptoms of schizophrenia are associated with higher overall morbidity and decreased functioning. These study results offer hope.

How does schizophrenia as a pathology differ from normal human experience?

Put out your cigarette. Researchers performed a cohort study of the impact of cigarette smoking on life expectancy in schizophrenia, schizoaffective disorder, and bipolar disorder.

Comorbidity or medication adverse effect? Researchers performed a nested case-control study of new-onset obsessive-compulsive disorder following antipsychotic use in schizophrenia.

Unintentional overdose with antipsychotics plus opioids. Researchers performed a population-based cohort study of the risk of overdose associated with co-prescription of antipsychotics and opioids.

All in a good night’s sleep? Researchers performed a pharmacovigilance study of second-generation antipsychotics and mood stabilizers as the suspected agent of psychiatric adverse drug reactions (insomnia and suicide/ideation/behavior/death).

Syllable and sound are still the primary means for taking the measure of thoughts and emotions, the building blocks and foundations of psychiatric work.

James L. Knoll IV, MD, shares insights from his decades in forensic psychiatry, where he has treated some of the criminal justice system’s most difficult and dangerous patients.

Different flowers need different levels of light, water, and shade. What would it mean to treat patients with a similar amount of care?

At the Annual Psychiatric Times World CME Conference, an all-star lineup of presenters will share their latest research. Check out this preview of the full agenda.

Mental illnesses are too often shrouded in secrecy and shame. What would happen if we spoke out about the cases we knew best—the ones in our own families?

Secondary causes for psychosis are more common in older adults (65 years or older) than in younger patients. Here are 6 possible culprits.